4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

Q: What does CUSIP 35104E100 represent in this 13F holders report?

CUSIP 35104E100 is the security identifier for FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q1 2023?

94 institutional investors reported FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q1 2023. Use the holders table for investor-level position and value details.

CUSIP: 35104E100

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 30,404,028
Total 13F value: $522,337,328
Share change: +2,404,067
Put/Call ratio: 135%
SEC-reported price per share: $17.19
Number of holders: 94
Value change: +$34,968,755
Number of buys: 52
Number of sells: 39
Shares outstanding: 51,571,939

Security key

35104E100

Report period

Q1 2023

Institutions

Top holders

FDMT full security history Ownership snapshot Full 13F holder table 4D Molecular Therapeutics, Inc. SEC filings 4D Molecular Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BVF INC/IL

Disclosed value leader

BVF INC/IL

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 7.8% Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL leads the comparable SEC ownership view at 7.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.

Comparable ownership Top 5

BVF INC/IL 7.8%

VIKING GLOBAL INVESTORS LP 7.6%

Deep Track Capital, LP 5.2%

BlackRock Finance, Inc. 4.9%

Janus Henderson Group Ltd. 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BVF INC/IL	13F Company 13F	7.8%	$89,004,643 4,007,413 shares	—	31 Dec 2022
VIKING GLOBAL INVESTORS LP	13F Company 13F	7.6%	$87,461,070 3,937,914 shares	—	31 Dec 2022
Deep Track Capital, LP	13F Company 13F	5.2%	$59,009,771 2,656,901 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	4.9%	$55,716,718 2,508,632 shares	—	31 Dec 2022
Janus Henderson Group Ltd.	13F Company 13F	2.8%	$32,562,787 1,466,267 shares	—	31 Dec 2022
MORGAN STANLEY	13F Company 13F	2.8%	$32,394,883 1,458,572 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

30,404,028

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %